Delivering Oral Dose of Insulin to Patients of Type 1 Diabetes: Trial Successful in Pigs

A new pill has been designed which delivers insulin into the bloodstream easily and pain-free, in pigs for now

Insulin is an important hormone required to break down the blood sugar – glucose – to prevent further illnesses. Since sugar is found in majority of diet which we consume including carbohydrates, dairy, fruits etc, insulin is needed every day to control blood sugar. Patients of diabetes need daily insulin injections as their pancreas is unable to produce this hormone adequately. If left untreated, diabetes can cause multiple health complications like heart stroke and kidney damage.

A new insulin pill

Taking injections administered in the stomach has been the traditional method for taking insulin for over a century. The main reason being that most drugs like insulin when taken orally do not survive the journey through our stomach and intestine to reach the bloodstream and so directly injecting them into blood is the only option. A team of researchers led by Massachusetts Institute of Technology, USA aimed to find an alternative way to take medications which otherwise require injection in their study published in Science. They have developed a pea-sized drug capsule which can deliver an oral dose of insulin to patients of Type 1 diabetes. Such a pill could eliminate use of daily insulin injections.

Innovative design

The drug capsule consists of a small single needle made from compressed insulin which gets automatically injected after the capsule is consumed and reaches the stomach. The tip of this needle is comprised of 100 percent compressed, freeze-dried insulin while the shaft is made of biodegradable polymer material and a little bit stainless steel as it doesn’t enter the stomach. The capsule was designed in an articulate way so that tip of the needle would always point to the tissue lining of the stomach allowing for targeted injection. Also, any movement like growling of the stomach would not affect the capsule’s orientation. They achieved this through computational modelling by creating a shape design variant which allows reorientation in the dynamic environment of the stomach. The needle is attached to a compressed spring held by a sugar disk.

Once the pill isswallowed, the sugar disk dissolves as soon as it comes in contact with gastric juice in the stomach, releasing the spring and acting as a trigger to inject the needle into the stomach wall.And since stomach lining does not have any pain receptors, patients wouldn’t feel anything making the delivery totally painless. Once the tip of the needle gets injected into the stomach wall, the microneedle tip made offreeze-dried insulin get dissolved at a controlled rate. In a duration of one hour, all the insulin gets released into the bloodstream. Researchers aimed to avoid any delivery inside of the stomach as stomach acids break down most drugs quickly.

Testing in pigs

Initial testing in pigs confirmed delivery of 200 micrograms of insulin and later 5milligramswhich is sufficient to lower blood sugar levels and is comparable to insulin injections given to Type 2 diabetes patients. After this task is finished, the capsule passes through the digestive system without causing any adverse effects.

Researchers are collaborating with Danish pharmaceutical Nova Nordisk, who are the biggest supplier of insulin and also co-authorsof this study, to manufacture these capsules for human trials to be conducted in next three years.They would also like to add a sensor which can track and confirm delivery of the dose.If this pill is successfully designed for human, the daily insulin injections would be a thing of the past and this would be very helpful for patients, especially children who are afraid of needles. The pill approach is more convenient, portable and also low on cost.

***

Source(s)

Abramson A et al. 2019. An ingestible self-orienting system for oral delivery of macromolecules. Science. 363. https://doi.org/10.1126/science.aau2277

***

Latest

Daraxonrasib Approved for Pancreatic Cancer

Daraxonrasib (Rasonque by Revolution Medicines, Inc.), an inhibitor of...

Glacial Collapse Led to Seismic Event in Nepal 

The magnitude 5.2 seismic event recorded near the border...

Significance of Nancy Grace Roman Space Telescope

Nancy Grace Roman Space Telescope (commonly referred to as...

NASA Invites ISRO to Join Moon Base Programme

NASA has invited ISRO (Indian Space Research Organisation) to...

2026 Total Solar Eclipse

On 12 August 2026, a total solar eclipse was...

AI Designs Complete Functional Genomes

The genome language model Evo 2 has designed novel...

Newsletter

Don't miss

MHRA Approves Moderna’s mRNA COVID-19 Vaccine

Medicines and Healthcare products Regulatory Agency (MHRA), the regulator...

Nuclear sites in Iran: No off-site radiation increase reported 

IAEA has reported “no increase in off-site radiation levels”...

Understanding Life-threatening COVID-19 Pneumonia

What causes severe COVID-19 symptoms? Evidences suggest inborn errors...

Mpox Disease: The Antiviral Tecovirimat (TPOXX) Found Ineffective in Clinical Trial

The monkeypox virus (MPXV), called so because of its...

A New Tooth-Mounted Nutrition Tracker

Recent study has developed a new tooth mounted tracker...

German Cockroach Originated in India or Myanmar  

The German cockroach (Blattella germanica) is world’s most common...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Daraxonrasib Approved for Pancreatic Cancer

Daraxonrasib (Rasonque by Revolution Medicines, Inc.), an inhibitor of the RAS GTPase family has been approved for the treatment of adults with metastatic pancreatic...

Glacial Collapse Led to Seismic Event in Nepal 

The magnitude 5.2 seismic event recorded near the border between Nepal and China on 26 August 2026 at 8:37 AM local time (02:52:10 UTC) has...

Significance of Nancy Grace Roman Space Telescope

Nancy Grace Roman Space Telescope (commonly referred to as Roman Telescope) is set to be launched into space on 30 August 2026. It will...